4//SEC Filing
Namouni Fouad 4
Accession 0001415889-24-024776
CIK 0001597264other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 5:09 PM ET
Size
5.5 KB
Accession
0001415889-24-024776
Insider Transaction Report
Form 4
Namouni Fouad
PRESIDENT, R & D
Transactions
- Sale
Common Stock
2024-10-03$89.32/sh−3,633$324,500→ 69,070 total
Footnotes (2)
- [F1]The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported is an average price. The shares were sold in multiple transactions ranging from $88.44 to $89.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001815851
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 5:09 PM ET
- Size
- 5.5 KB